AIM ImmunoTech Inc. (AIM) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the AIM Immunotech fourth quarter and full year 2024 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode. If anyone requires operator assistance during the event, please press star zero on your telephone keypad. Following the presentation will be a question and answer session. Note that this webcast is being recorded at the company's request and a replay will be the company's website following the end of the event. At this time, I would like to remind our listeners that remarks made during the webcast may state management's intentions, beliefs, expectations, or future projections. These are forward-looking statements that involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the Federal Securities Law Center based on AIM Immunotech's current expectations and actual results for different materiality. As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results of different materiality from these contemplated by such forward-looking statements are discussed in the periodic reports in immunotech files with the Securities and Exchange Commission. These documents are available in the Investors section of the company's website and on the Securities and Exchange Commission's website. We encourage you to view these documents carefully. Additionally, certain information contained in the webcast relates to or is based on studies, publications, surveys, and other data obtained from third-party sources of the company's own estimates and research. While the company believes these third-party sources to be reliable as of the date of this presentation, it is not...